Proniosomal transdermal therapeutic system of losartan potassium: development and pharmacokinetic evaluation

By Thakur Reena   Anwer Md Khalid   Shams Mohammad   Ali Asgar   Khar Roop   Shakeel Faiyaz   Taha Ehab  

Journal of Drug Targeting, Vol. 17, Iss. 6, 2009-07 ,pp. : 442-449

Informa Healthcare

Access to resources Recommend Favorite

Losartan for the treatment of hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study

By Devereux Richard B   Lyle Paulette A  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2311-2320

Informa Healthcare

Access to resources Recommend Favorite

Effects of Losartan and Delapril on the Fibrinolytic System in Patients with Mild to Moderate Hypertension

By Paterna S.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 717-724

Adis International

Access to resources Recommend Favorite

Losartan/Hydrochlorothiazide: A Review of its Use in the Treatment of Hypertension and for Stroke Risk Reduction in Patients with Hypertension and Left Ventricular Hypertrophy

By Keating Gillian M.  

Drugs, Vol. 69, Iss. 9, 2009-06 ,pp. : 1239-1265

Adis International

Access to resources Recommend Favorite

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder

By Frampton James E.   Plosker Greg L.  

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite